Back to AVTX

Trails Edge Capital Partners, LP → AVTX

Trails Edge Capital Partners, LP AVTX Position History

Avalo Therapeutics, Inc. • Healthcare

Quarters held
2
Latest value
$23M
Q3 2026
Peak value
$23M
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$16.5M
Q3 2026$23M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$23M1.50M——
Q2 2026$16.5M891.9K——

Other funds holding AVTX

Other Trails Edge Capital Partners, LP positions

LBRX

LB PHARMACEUTICALS INC

$49.4M
LBRX

LB PHARMACEUTICALS INC

$44.1M
BMRN

BIOMARIN PHARMACEUTICAL INC

$40M
PCVX

VAXCYTE INC

$38.5M
NRIX

NURIX THERAPEUTICS INC

$38.2M
ACAD

ACADIA PHARMACEUTICALS INC

$37.9M
NRIX

NURIX THERAPEUTICS INC

$37.3M
OBX

OBSIDIAN THERAPEUTICS INC

$34.3M